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Maintenance of cellular integrity in Saccharomyces
cerevisiae is carried out by the activation of the protein
kinase C-mediated mitogen-activated protein kinase
(PKC1-MAPK) pathway. Here we report that correct
down-regulation of both basal and induced activity of
the PKC1-MAPK pathway requires the SIT4 function.
Sit4 is a protein phosphatase also required for a proper
cell cycle progression. We present evidence demonstrat-
ing that the G1 to S delay in the cell cycle, which occurs
as a consequence of the absence of Sit4, is mediated by
up-regulation of Pkc1 activity. Sit4 operates down-
stream of the plasma membrane sensors Mid2, Wsc1, and
Wsc2 and upstream of Pkc1. Sit4 affects all known bio-
logical functions involving Pkc1, namely Mpk1 activity
and cell wall integrity, actin cytoskeleton organization,
and ribosomal gene transcription.
The Saccharomyces cerevisiae gene SIT4 codes for a Ser/Thr
protein phosphatase member of the PPP phosphatase family
that is closely related to the PP2A family (1, 2). Sit4 displays a
high level of identity to both the fission yeast phosphatase ppe1
and the human protein phosphatase 6, which are involved in
cell cycle regulation (3, 4). Sit4 participates in a number of
cellular processes such as the Tor pathway-mediated response
to nutrients (5–7) and the regulation of monovalent ion home-
ostasis and intracellular pH (8). Sit4 also plays an important
role in cell cycle regulation, as it is required for the proper G1
to S phase transition (9, 10). Cells deleted for SIT4 are either
nonviable or display slow growth because of an expanded pas-
sage through G1 (9, 11–13). This delay is partly because of the
role of SIT4 in the normal transcription control of the G1 cyclin
genes CLN1 and CLN2, and also in the control of SWI4, coding
for a DNA-binding protein required for transcriptional modu-
lation of CLN1/CLN2 (14, 11). In addition, SIT4 is believed to
function in a pathway parallel to CLN3 for the activation of
CLN1 and CLN2 expression through BCK2 (15).
Ppz1 and Ppz2 (16, 17) represent another subset of Ser/Thr
protein phosphatases, which play an opposite role to Sit4 in cell
cycle regulation (13). The absence of PPZ1 compensates for the
delay in cyclin accumulation and also alleviates the budding
defect observed in a sit4 mutant (13). PPZ1 has been report-
edly involved in the maintenance of cell integrity in cooperation
with the PKC1-mitogen activated protein kinase (MAPK)1
pathway (17). Overproduction of Ppz1 suppresses the lysis
phenotype of null mutants in PKC1 and MPK1 (17). The PKC1-
MAPK pathway is a phosphorylation cascade that responds to
signals related to yeast cell integrity, such as: mating phero-
mone (18), low osmolarity (19), and high temperatures (20).
Mpk1/Slt2 is the last kinase member of the pathway. Simulta-
neous deletion of MPK1 and PPZ1 is lethal for the cell (17).
Cell wall stress is detected by the plasma membrane sensors
Mid2 (21), Wsc1/Hsc77/Slg1, Wsc2, and Wsc3 (22, 23), and the
signal is transmitted downstream via the GTP-binding protein
Rho1 that activates the PKC1-MAPK module (21, 22). Pkc1
phosphorylates the MAPK kinase kinase Bck1 (24), which in
turn, transmits the signal to the redundant MAPK kinases:
Mkk1 and Mkk2 (25). These finally phosphorylate the Slt2/
Mpk1 MAPK (26) on both Tyr192 and Thr190 residues (19, 27,
28) causing the activation of the kinase. Phosphorylation and
activation of Mpk1 leads to a number of cellular responses.
Thus, activation of Mpk1 results in phosphorylation of the
transcriptional factor Swi6 through which the pathway is
linked to the cell cycle regulatory machinery (29, 30). The
PKC1 pathway is also involved in budding control (18) and cell
wall synthesis (21), by regulating (i) the expression (often in a
cell cycle-dependent fashion) of several genes coding for pro-
teins related to cell wall synthesis and structure (31–34), and
(ii) the organization of the actin cytoskeleton (35).
Genetic evidence indicates that Ppz1/Ppz2 phosphatases act
independently of the PKC1-MAPK pathway (17). Their role
therefore seems to be different from that of other phosphatases,
such as Ptp2/Ptp3 (36) or Msg5 (37), which are known to
dephosphorylate and negatively regulate certain components of
the pathway. The observation that Ppz1 and Sit4 exhibit a
functional antagonism in cell cycle regulation (13) prompted us
to investigate whether this antagonism could also be extended
to the functional connection with the PKC1 pathway.
Here we demonstrate that Sit4 is required for down-regula-
tion of Pkc1 activity, and is consequently needed for a number
of functions that depend on this kinase, such as Mpk1 activity,
cytoskeleton organization, ribosomal gene expression, and cell
cycle progression.
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MATERIALS AND METHODS
Yeast Strains, Culture Medium, and Genetic Methods—The S. cer-
evisiae strains used in this work are listed in Table I. Unless otherwise
stated, they are derived from either CML125 or CML128 wild type
strains (38). The following strains were obtained from their correspond-
ing diploids by tetrad analysis: MML200 and MML203 from MML182,
MML216 from MML185, MML231 and MML233 from MML230, and
MML344 and MML345 from MML282.
Yeast cells were usually grown in YPD medium (2% yeast extract, 1%
peptone, 2% glucose) or in the selective glucose minimal medium, SD
(0.67% yeast nitrogen base, 2% glucose, and the required amino acids)
(39). Where indicated, D-sorbitol was added to a final concentration of 1
M. To repress expression of the PKC1 gene under the tetO7 promoter
(40), cells were, respectively, grown in SD plus 10 g/ml doxycycline
until early log phase, then filtered and washed in the same medium
without doxycycline. Cells were then resuspended in YPD and incu-
bated for 6 h at 25 °C. After that, cultures were split in two. One-half
was kept at the same temperature and the other was shifted to 37 °C for
30 min. Cells were subsequently collected by filtration and treated for
total protein extraction as described in Ref. 41.
Yeast transformations were performed as described in Ref. 42. The
MPK1 gene was disrupted using a URA3 cassette (26). The URA3
marker from Candida albicans (43) was used to disrupt the WSC1 gene
according to the one-step disruption method (44). This method was also
employed to disrupt the MID2, BCK1, and MSG5 genes with the
kanMX4 module and the WSC2 gene with the natMX4 module (45).
DNA Manipulation and Plasmids—DNA manipulation, plasmid re-
covery, and bacterial transformation were performed according to
standard methods (46). Escherichia coli DH5 (Invitrogen) was used for
plasmid amplification.
YEplac195-SIT4 (TRP2) plasmid harbors a genomic 2.65-kb SnaBI-
NheI fragment containing the SIT4 gene cloned in the SmaI-XbaI
restriction site of YEplac195 (47). Plasmid pMM66 is a YEplac195
derivative (URA3/2) (48) containing MSG5 under its own promoter
cloned at the SmaI vector site. MSG5 was amplified by PCR from yeast
genomic DNA. Plasmid pMM69 is a YEplac195 derivative harboring
(PCR-amplified) PTP2 under its own promoter and cloned into the KpnI
and HindIII vector sites. Plasmid pMM126 is a pCM265 derivative
(URA3/ CEN) (40) that contains PCK1 under the tetO7 promoter and is
tagged with three copies of the HA epitope at the N terminus of the
protein. The PCK1-coding sequence was obtained from genomic DNA by
PCR and directionally cloned into PmeI and PstI vector sites (47). The
pRS413-BCK1–20 plasmid is described in Ref. 24. The pMpk1-HA plas-
mid is a YEP352 derivative, Mpk1 ORF is cloned under its own pro-
moter and HA-tagged in C-terminal (a gift from Maria Molina, Univer-
sity Complutense, Madrid, Spain).
Cell Synchronization—For synchronization experiments, cells were
exponentially grown to 107 cells/ml. S and G2 arrests were performed
with hydroxyurea and nocodazole, respectively, at the concentrations
indicated in the text. G1 arrests were performed either by -factor
treatment (10 g/ml) or by elutriation. All cell cycle arrests were per-
formed at 25 °C for 2 h in the case of the wild type strain and for 4 h in
the case of the sit4 mutant. Cells were elutriated according to the
protocol described in Ref. 48. Fluorescence-activated cell sorting (FACS)
sample analysis (49) was used to confirm correct synchronization.
Actin Staining—Cells were stained with rhodamine-phalloidin as
described in Ref. 50.
Yeast Extracts and Immunoblot Analyses—For Western analysis,
cells were collected on ice, filtered through 0.22-Millipore membranes,
washed with ice-cold medium, transferred to Eppendorf tubes with 1 ml
of ice-cold medium, and then centrifuged for 30 s at 13,000 rpm. Total
yeast protein extracts were prepared in ice-cold lysis buffer (75 mM
Tris-HCl, pH 7.5, 0.45 M KCl, 10% glycerol, 1 mM phenylmethylsulfonyl
fluoride, 1 mM L-1-tosylamido-2-phenylethyl chloromethyl ketone, 1 mM
pepstatin, 1 mM -glycerophosphate, 1 mM EGTA, 5 mM sodium pyro-
phosphate, and the protease inhibitors chymostatin, leupeptin, and
antipain each at 5 nmol/l). After the addition of SDS to a final con-
centration of 1%, lysates were then boiled at 95 °C for 5 min. Equivalent
amounts of total protein extracts were run on SDS-PAGE gels with 10%
acrylamide. The anti-phospho-p44/p42 antibody (New England Biolabs)
was used at a final dilution of 1:2000 in TBST buffer. The anti-Swi6
antibody was used at a dilution of 1:10,000 in the same buffer, and the
anti-GST-Mpk1 antibody (37, 51) at a dilution of 1:1000 in the presence
of 5% fat milk (51). Horseradish peroxidase-linked secondary antibod-
ies, anti-rabbit, or anti-mouse (NA931 and NA934, Amersham Bio-
sciences), were used at a 1:10000 dilution and incubated in TBST buffer
containing 2% fat milk for the anti-phospho-Mpk1 and 0.25% fat milk
for the other two primary antibodies. Chemiluminescent detection was
performed using the Supersignal substrate (Pierce) in a Lumi-Imager
(Roche Molecular Biochemicals).
Kinase Activity—Immunoprecipitation of Pkc1 and in vitro protein
kinase assays were performed using either myelin basic protein (frag-
ment 4-14, Sigma) or a Bck1-Ser939 synthetic peptide according to Ref.
41. To inhibit Pkc1 activity, 4  109 M staurosporine was added to the
kinase reaction (52). Mpk1 immunoprecipitation and protein kinase
assay were conducted following the protocol described in Ref. 20.
RESULTS
The Absence of Sit4 Leads to a Specific Up-regulation of
Slt2/Mpk1 MAP Kinase Activity—We had previously tested
Mpk1 basal and heat shock-induced levels of activity in a ppz1
mutant and observed that they were severely impaired (data
not shown).2 To examine whether Mpk1 phosphorylation levels
were higher in the absence in Sit4 than in wild type cells
(antagonically to that observed in the ppz1 mutant), we used
2 M. A. de la Torre-Ruiz, J. Torres, J. Arin˜o, and E. Herrero, unpub-
lished observations.
TABLE I
Yeast strains used in this work
Strain Relevant genotype Ref.
CML125 MAT leu2–3,112 ura3–52 trp1 his4 can1r This work
CML128 MATa as CML125 Gallego et al. (39)
JA-110 MATa sit4TRP1 Clotet et al. (13)
JA-117 MATa sit4kanMX4 Clotet et al. (13)
CML399 MATa mpk1URA3 This work
MML182 MATa/ SIT4/sit4TRP1 BCK1/bck1kanMX4 This work
MML200 MAT bck1kanMX4 This work
MML203 MATa sit4TRP1 bck1kanMX4 This work
MML282 MATa/ PKC1/pkc1LEU2, SIT4/sit4kanMX4 This work
MML302 MAT pkc1LEU2 sit4kanMX4(pBCK1–20) This work
MML304 MAT pkc1LEU2(pBCK1–20) This work
MML344 MATa pkc1LEU2 This work
MML345 MAT pkc1LEU2 sit4kanMX4 This work
MML382 MATa wsc1CaURA3 This work
MML384 MATa wsc2natMX4 This work
MML387 MATa mid2kanMX4 This work
MML388 MATa mid2kanMX4 sit4TRP1 This work
MML392 MATa wsc1CaURA3 wsc2natMX4 This work
MML393 MATa wsc1CaURA3 mid2kanMX4 This work
MML398 MATa wsc2natMX4 sit4TRP1 This work
MML400 MATa wsc1CaURA3 wsc2natMX4 sit4TRP1 This work
MML400 MATa wsc1CaURA3 mid2kanMX4 sit4TRP1 This work
MML402 MATa wsc1CaURA3 sit4TRP1 This work
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the anti-phospho-p44/42 MAPK antibodies raised against du-
ally phosphorylated (Thr202/Tyr204)-p44/42 MAPK. These anti-
bodies allow accurate monitoring of Mpk1 activity (23, 37).
Wild type and sit4 cells were grown at 25 °C and then shifted
at 37 °C for various time periods (Fig. 1A). sit4 cells showed
increased basal phosphorylation levels as compared with wild
type cells (Fig. 1A). Upon heat shock, Mpk1 phosphorylation
was much more intense in mutant than wild type cells, and
remained higher for longer periods. These changes could not be
ascribed to variations in the total amount of Mpk1 protein, as
their levels remained constant in all cases, a fact deduced by
probing the same protein samples with an anti-GST-Mpk1
antibody (Fig. 1A). Quantification and normalization of phos-
phorylation levels revealed that after 30 min of heat shock,
Mpk1 phosphorylation levels in the sit4mutant were 10 times
higher than in wild type cells (Fig. 1B). We performed an in
vitro Mpk1 kinase assay in order confirm that the dual Mpk1
phosphorylation detected with the p44/42 antibody correlated
to Mpk1 activity. As expected, we were able to detect greater
Mpk1 kinase activity levels in sit4 exponentially growing
cells, both at 25 °C or after 30 min of shifting cells at 37 °C
compared with the wild type (Fig. 1C). To prove that the in-
crease in Mpk1 activity observed in a sit4 strain was not
because of an indirect effect caused by the lack of this gene, we
performed overexpression analyses by using a multicopy plas-
mid carrying Sit4 under its own promoter. Sit4 overexpression
provoked a dramatic decrease in both the basal and induced
phosphorylation state of Mpk1 in wild type cells (Fig. 1D),
which demonstrates that Sit4 exercises specific regulatory con-
trol over Mpk1 activity.
We reasoned that if Mpk1 was hyperphosphorylated in cells
lacking Sit4, this could result in biological changes derived
from kinase activation. To test this we examined the phospho-
rylation of Swi6 (a transcription factor whose phosphorylation
after heat shock depends on Pkc1-mediated Mpk1 activation
(29, 30, 53)).
We monitored Swi6 phosphorylation with polyclonal anti-
bodies that detect two forms of the protein in wild type cells: a
faster migrating band corresponding to the hypophosphory-
lated Swi6 state and a slower mobility hyperphosphorylated
Swi6 band. In nonstressed wild type cells only the hypophos-
phorylated form was detected, and shifting the cells to 37 °C
resulted in the appearance of hyperphosphorylated Swi6 (Fig.
1A). In contrast, in sit4 cell extracts hyperphosphorylated
Swi6 was readily observed at 25 °C. Moreover, after heat shock
the proportion of this form dramatically increased with respect
to wild type cells, and remained higher throughout the exper-
iment (Fig. 1A). Hyperphosphorylation of Swi6 in sit4 cells
after heat shock was fully mediated by Mpk1, as no changes in
mobility were observed in a sit4-mpk1 double mutant (data
not shown). In conclusion, the above results point to Sit4 being
necessary for negative modulation of Mpk1 activity and, con-
sequently also for downstream processes dependent on this
activity.
The Absence of Sit4 Affects Mpk1 Phosphorylation at All
Phases of the Cell Cycle and Is Not the Result of Intrinsic Cell
Wall Defects—It could be hypothesized that the increased ac-
tivation of Mpk1 found in sit4 cells derives from intrinsic cell
wall defects in the mutant that would lead to constitutive
hyperactivation of the PKC1-MAPK pathway. To test this pos-
sibility, we monitored Mpk1 phosphorylation in cells growing
in the presence of 1 M sorbitol used as an osmotic stabilizer.
This condition prevented Mpk1 phosphorylation when the cell
wall was severely stressed (34). Growth in the presence of
sorbitol resulted in reduced Mpk1 phosphorylation after the
shift to 37 °C (Fig. 2A). However, the presence of the stabilizer
did not prevent Mpk1 basal phosphorylation in a sit4 mutant
with respect to other wild type cells. Therefore, hyperactivation
of Mpk1 in the absence of Sit4 is not a consequence of hypo-
thetical cell wall defects derived from the lack of Sit4. In fact,
a sit4 mutant showed increased tolerance to treatment with
zymolyase (a combination of 1,3--glucanase and protease en-
FIG. 1. Mpk1 activity is up-regulated in the absence of SIT4. A,
log phase cultures of wild-type (CML128) and sit4 cells were grown in
YPD at 25 °C (time 0) and shifted at 37 °C for the indicated periods.
Anti-phospho-p44/p42 was used to detect Mpk1 phosphorylation, anti-
Gst-Mpk1 to quantify total amounts of Mpk1 protein, and anti-Swi6 to
detect the Swi6 phosphorylation state. B, histograms represent Mpk1
phosphorylation levels relative to total Mpk1 protein (arbitrary units)
from a representative experiment, quantified using a CCD Lumi-
Imager chamber (Roche Molecular Biochemicals). C, wild type and
sit4 cells were transformed with a multicopy plasmid carrying Mpk1
HA-tagged in C-terminal. Samples were collected from exponentially
growing cultures either at 25 °C or after 30 min of shifting cells at
37 °C. Histograms represent arbitrary units of Mpk1 kinase activity
using myelin basic protein as a substrate. Mpk1-HA immunoprecipi-
tates are shown in the inset. D, cultures from sit4 and CML128 cells,
transformed with the Yep-Sit4 multicopy plasmid, were exponentially
grown in SD media plus amino acids at 25 °C. Cultures were washed
and transferred to fresh YPD media for 4 h at 25 °C (time 0), then
shifted at 37 °C for the times indicated.
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zymes that degrade the yeast cell wall) with respect to wild
type cells (Fig. 2B). In contrast, as previously described (34) the
mpk1 mutant was hypersensitive to enzymatic digestion.
Exponentially growing cultures of sit4 are enriched in G1
cells, and it has been reported that Mpk1 becomes phosphoryl-
ated at the G1/S transition in a cell cycle-dependent manner
(18). Increased Mpk1 dual-phosphorylation in a sit4 mutant
could therefore result from the presence of a higher proportion
of cells in G1 in asynchronous cultures. To discard this possi-
bility, we performed heat-shock experiments with cells syn-
chronized with -factor in G1, in S with hydroxyurea, and in G2
with nocodazole. In all three cases basal and heat-induced
Mpk1 phosphorylation were higher in sit4 than in wild type
cells (Fig. 2C). As these treatments are somewhat stressful for
cells and might affect Mpk1 phosphorylation, G1 small daugh-
ter cells were recovered by elutriation, and allowed to progress
through the cell cycle, to monitor Mpk1 phosphorylation. At all
tested time points, Mpk1 phosphorylation in sit4 cells was
more intense than in wild type cells (Fig. 2D). It can therefore
be concluded that the absence of Sit4 affects Mpk1 phosphoryl-
ation regardless of its position in the cycle. This also demon-
strates that the higher activity detected in sit4 cells is not
merely a circumstantial effect caused by the partial synchroni-
zation in G1 in this mutant.
Sit4 Functions Upstream of Pkc1 and Negatively Regulates
Its Activity—We constructed pkc1-sit4 and bck1-sit4 dou-
ble mutants to investigate whether the induction of Mpk1
activity that occurs in the absence of Sit4 was dependent on
Pkc1. However, neither Mpk1 phosphorylation nor Swi6 hyper-
phosphorylation were observed in pkc1-sit4 (Fig. 3A, and
data not shown) or bck1,sit4 (not shown) double mutants at
25 or 37 °C. We conclude that an intact PKC1-MAPK module is
required for the Mpk1 activation caused by the absence of Sit4
function. This points against Sit4 defining a Mpk1-inactivating
pathway independent from Pkc1.
We followed two different approaches to functionally situate
Sit4 with respect to Pkc1. First, we used a BCK1–20 allele that
constitutively activates Mpk1 (24). We transformed the PKC1/
pkc1SIT4/sit4 diploid strain using a plasmid bearing the
BCK1–20 allele. After sporulation, the pkc1,sit4, pkc1, and
sit4 strains (bearing the pBCK1–20 plasmid) were isolated
and Mpk1 phosphorylation was subsequently analyzed. It is
important to stress that after heat shock Mpk1 still became
hyperactivated in the presence of a BCK1–20 allele (not
shown). Our reasoning was therefore as follows: if Sit4 acts
downstream of Pkc1 as a negative regulator for the pathway,
then both sit4/pBCK1–20 and pkc1-sit4/pBCK1-20 cells
would exhibit higher levels of Mpk1 activity than wild type and
pkc1 cells transformed with pBCK1–20, respectively. Alter-
natively, if Sit4 acts upstream of Pkc1 we would first expect the
constitutive phosphorylation level of Mpk1 in sit4/pBCK1–20
cells to be higher than in any of the other strains tested, and
second we would expect pkc1-sit4/pBCK1-20 and pkc1/
pBCK1–20 cells to exhibit the same constitutive levels of Mpk1
activity, revealing that in the absence of Pkc1 the lack of Sit4
would have no effect on Mpk1 phosphorylation. In fact, and as
predicted by the second hypothesis, in pkc1-sit4/pBCK1-20
and pkc1/pBCK1–20 strains, the constitutive activity of Mpk1
was lower than that observed in wild type/pBCK1–20 cells. We
also observed that the absence of Sit4 together with the pres-
ence of the BCK1–20 allele had an additive effect on basal
levels of Mpk1 activity (Fig. 3B). However, this sit4-mediated
additive effect was suppressed when PKC1 was deleted. This
suggested that up-regulation of Mpk1 phosphorylation in sit4/
pBCK1–20 cells was the result of two independent processes,
one because of constitutive Mpk1 activation caused by the
BCK1–20 allele and the other because of up-regulation of Pkc1
activity in the absence of Sit4. These results support the hy-
pothesis that situates Sit4 upstream of Pkc1. To confirm this,
in a second approach we sought to determine Pkc1 kinase
activity using two different substrates. In both, wild type and
sit4 cells were transformed with a centromeric plasmid bear-
FIG. 2. The high Mpk1 activity in sit4 mutants is not relieved
by sorbitol and does not depend on the cell cycle stage. A,
CML128 and sit4 cells were exponentially grown at 25 °C (time 0) in
YPD  1 M sorbitol and shifted to 37 °C. B, cells from wild type, sit4,
and mpk1 were cultured in YPD at 24 °C to mid-log phase and sub-
sequently treated with 1 unit/ml zymolyase 100T for the indicated
times, according to de Nobel et al. (34). Cell lysis was estimated by
measuring A600. Values represent the average of three independent
experiments. C, cultures from wild type and sit4 cells were exponen-
tially grown at 25 °C (time 0) in YPD medium and synchronized at
different stages of the cell cycle: in G1 with 10 g/ml -factor, in S phase
with 200 g/ml HU (hydroxyurea), and in G2 with 10 g/ml nocodazole
(NOC). Following treatments, cultures were shifted from 25 to 37 °C. In
all cases, arrest was maintained throughout the experiment. D, cells
from wild type and sit4 log-phase cultures were elutriated in G1 as
described under “Materials and Methods.” After collection, cells were
transferred to fresh YPD medium at 25 °C and allowed to progress up
to the second cell cycle. Immunoblot analyses using anti-Swi6, anti-
phospho-p44/p42 (bands shown in the figure), and anti-GST-Mpk1 were
performed as described in the legend to Fig 1. In all cases, we made a
parallel Western blot using the same samples to quantify the total
amount of Mpk1 with anti-GST-Mpk1 antibody and confirmed that
equal levels of this protein were detected in all lines (data not shown).
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ing the Pkc1-HA-tagged protein under control of a regulatable
tet promoter (40). We obtained the same results with both
substrates: basal activity was barely detectable. However, Pkc1
activity induced after heat shock was much higher in sit4
than in wild type cells, and was suppressed after the addition
of the Pkc1 inhibitor staurosporine (Fig. 3C). These results
confirmed that Sit4 is required to negatively modulate Pkc1
activity in the cell integrity pathway.
We next studied Mpk1 phosphorylation in mutants lacking
SIT4 and WSC1, WSC2, or MID2 plasma membrane receptor
genes. In the case of both sit4-wsc1, and the sit4-mid2
double mutants, Mpk1 phosphorylation was markedly more
induced than in wsc1-mid2, and wild type cells at the re-
spective temperatures (Fig. 3D). To simplify the figure we did
not include the results obtained with the wsc2mutant as they
were similar to those obtained with wsc1. To ascertain
whether Sit4 is a regulator of more than one cell wall receptor
(this could explain why we were unable to detect such a regu-
lation when using single mutants), we constructed the wsc1-
wsc2 and wsc1-mid2 double mutants and corresponding
triple mutants in combination with sit4. Again, in both
wsc1-wsc2-sit4 and wsc1-mid2-sit4 triple mutants,
both basal and induced Mpk1 activity was higher in wild type
cells and double mutants, and was equivalent to the Mpk1
phosphorylation levels observed in the sit4 strain (Fig. 3E).
Bem2 is a GTPase activating protein that down-regulates Rho1
(54). Recent proteomic studies have shown that Bem2 and Sit4
along with other proteins form part of the same protein com-
plex (55). Because both basal and induced Mpk1 activity are
increased in bem2 compared with wild type cells (37), we
wondered whether Sit4 might be regulating Bem2 activity. We
observed that in the sit4-bem2 double mutant there was an
additive effect in the increase of basal Mpk1 (2.5-fold) and heat
shock-induced phosphorylation (2-fold) with respect to both
single mutants (Fig. 3F). This result discards the possibility of
Sit4 being a regulator for Bem2 GTPase. Taken together, these
results suggest that Sit4 operates downstream of Mid2, Wsc1,
and Wsc2 membrane receptors, independently of Bem2 and
upstream from Pkc1.
The Absence of Sit4 Stimulates Transient Heat Shock-in-
duced PKC1-dependent Actin Cytoskeleton Depolarization—
Heat shock induces transient depolarization of the actin cy-
toskeleton (56, 57) mediated by upper cell integrity pathway
components WSC1 and ROM2 (22). Rho1 and Pkc1 hyperacti-
vation also induces depolarization of the actin cytoskeleton in
the absence of heat stress (22). We examined actin polarization
in both wild type and sit4 cells to determine whether Sit4 was
also involved in the regulation of this process. Both wild type
FIG. 3. Sit4 is not epistatic to the
PKC1-MAP pathway, and functions
upstream of Pkc1 in the modulation
of the pathway activity. A, mid-log cul-
tures from wild type, sit4-pkc1, and
sit4-pkc1 strains growing at 25 °C
were shifted to 37 °C for 30 min. B, expo-
nential cultures of the following strains at
25 °C: sit4/pBCK1–20, sit4-pkc1/
pBCK1–20, pkc1/pBCK1–20, and
CML128/pBCK1–20 were grown as de-
scribed in the legend to Fig. 2 and sam-
ples were taken at 25 °C for Western blot.
Asterisk represent values corresponding
to the amount of phosphorylated Mpk1
relative to total GST-Mpk1 protein for
each strain. C, wild type and sit4 cells
were transformed with a plasmid carry-
ing the Pkc1-HA-tagged protein under
the control of the tetO7 promoter. Growth
conditions and protein preparation are
described under “Materials and Meth-
ods.” Histograms represent arbitrary
units of Pkc1 kinase activity using two
different Pkc1 substrates. Pkc1-HA im-
munoprecipitates are shown in the inset.
St, staurosporine. Schematic representa-
tion of some of the elements of the cell
integrity pathway used in this study. D,
mid-log cultures from sit4, wild type,
wsc1, sit4-wsc1, mid2, and sit4-
mid2 strains growing at 25 °C were
shifted at 37 °C for 30 min. E, mid-log
cultures from sit4, wild type, sit4-
wsc1-wsc2, wsc1-wsc2, sit4-wsc1-
mid2, and wcs1-mid2 strains growing
at 25 °C were shifted at 37 °C for 30 min.
F, exponentially growing wild type,
bem2-sit4, and bem2 cells at 25 °C
() were shifted to 37 °C for 30 min ().
Equal amounts of total protein extracts
were loaded onto SDS-polyacrylamide
gels and subsequently immunoblotted
with the anti-phospho-p44/p42 antibody.
Except in part C, the bands shown in the
figure correspond to phospho-Mpk1. The
levels of total Mpk1 detected with the an-
ti-GST-Mpk1 antibody were similar in
each sample (data not shown).
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and sit4 cells showed normal actin distribution at 25 °C,
whereas random actin disorganization occurred after 30 min at
37 °C. However, whereas normal actin distribution was re-
stored in wild type cells after 90 min, in the case of the sit4
mutant this was only achieved 3 h after heat shock (Fig. 4).
This effect could be explained by the fact that Pkc1 activity
after heat shock is greater in a sit4 mutant and remains
greater for longer than in wild type cells (data not shown). The
actin defect observed in sit4 cells was not because of the slow
growth rate described for this mutant, because in the double
mutant sit4-ppz1, in which the cell cycle defect caused by the
absence of Sit4 was largely relieved (13), the actin cytoskeleton
remained depolarized long after heat shock as in sit4 cells
(data not shown). We conclude from these results that Sit4 also
affects another known Pkc1 function, namely the transient
depolarization of the actin cytoskeleton that occurs after envi-
ronmental stress.
Sit4 Also Regulates the PCK1 Function Required for Tran-
scriptional Repression of Ribosomal Genes—Transcriptional re-
pression of ribosomal proteins (RP) after alteration of the yeast
secretory pathway requires Pkc1 but not Mpk1 activity (58).
We studied the transcriptional levels of the RPL30 and RPL6A
ribosomal genes in sit4 and wild type cells to test whether this
process was also affected by Sit4 function. We shifted sit4 and
wild type cultures from 25 at 37 °C for half an hour to maximize
the differences in Pkc1 activity between sit4 and wild type
cells (see Fig. 1). We then treated or mock treated cells with
tunicamycin to block their secretory machinery and took sam-
ples at various time intervals. It has been reported that Pkc1 is
not required for repression of ribosomal mRNA after a heat
shock, and that this repression occurs via a different pathway
than that responding to a secretory defect (59). In accordance
with this theory, no significant differences were observed in
relative levels of RPL30 and RPL6A mRNAs or between sit4
and wild type cells after 30 min at 37 °C (Fig. 5), despite the
large differences in Pkc1 activity reflected in Mpk1 phospho-
rylation (Fig. 1A). However, upon addition of tunicamycin, RP
relative mRNA levels decreased significantly faster in sit4
than in wild type cells (Fig. 5, A and B), although with no
apparent changes in ACT1 and U1 mRNA levels (data not
shown). Nevertheless in mock treated cells mRNA levels
showed a significant increase after heat shock that was main-
tained throughout the experiment (Fig. 5, C and D), in accord-
ance with Ref. 59. Using anti-invertase polyclonal antibodies
we could not detect differences in the invertase accumulation
between wild type and sit4 cultures (data not shown) by
Western blot, which indicates that the results shown above
were not a reflection of intrinsic problems in secretion in the
sit4 mutant. The lack of RP mRNA repression observed in a
pkc1 mutant, under conditions in which the secretory path-
way was altered by tunicamycin, was also observed in the sit4
pkc1 double mutant (data not shown), which means that in
the absence of Sit4, Pkc1 activity was still required for this
response. The greater RP mRNA repression observed in sit4
cells is therefore a Pkc1-dependent response to secretory prob-
lems. Our data indicate that Sit4 is also needed in a signaling
process leading to ribosomal gene expression and that this is
dependent on Pkc1 activity but not on downstream elements of
the MAP kinase pathway.
Pkc1 Is Involved in the G1 to S Delay Observed in the Absence
of Sit4—As previously reported, cells lacking Sit4 display a
marked defect in the G1 to S progression through the cell cycle
(Ref. 9 and Fig. 6B), which results in slower growth compared
with wild type cells (Fig. 6C). Interestingly, when we overex-
pressed Pkc1 under the tet promoter we induced an extended
G1 phase in wild type (Fig. 6A) and sit4 (not shown) cultures
that provoked an increase in generation time in both strains.
This was reflected in the accumulation of cells at G1 in expo-
nentially growing cultures (Fig. 6A), which resembled sit4
FACS profiles. This delay in G1 was also observed when we
overexpressed the constitutively active allele PKC1
(R398,R405A,K406A) under the Gal promoter (not shown).
Pkc1 overexpression also provoked an increase in Mpk1 activ-
ity (Fig. 6A). Given the correlation observed between Mpk1
basal activity and G1 delay between the sit4 mutant and cells
overexpressing Pkc1, we speculated that high levels of PKC1-
MAPK activity would induce a G1 delay. This could explain
why, in the absence of Sit4, the cell cycle was extended in G1,
in comparison with wild type cells. Following this line of rea-
soning, we would expect sit4 cells not to display a G1 defect in
the absence of Pkc1. As shown in Fig. 7B, pkc1 deletion
efficiently suppressed the accumulation of cells in sit4 cul-
tures at G1. In all cases, cells were grown in rich medium plus
the osmotic stabilizer sorbitol (1 M) to prevent cell lysis because
of the absence of Pkc1. In support to this, sit4-pkc1 and also
pkc1 populations displayed similar generation times of about
180 min at 25 °C growing in rich medium plus sorbitol, very
similar to that of wild type cells (Fig. 6C). Even so, the sit4
cells doubling time was twice as long as that observed in the
above mentioned cultures. This phenotype must be specific to
FIG. 4. Sit4 was required for Pkc1-
dependent normal depolarization of
the actin cytoskeleton. Wild type
(CML128) and sit4 cells were grown
in rich medium at 25 °C, shifted at 37 °C
for the indicated times to be fixed, and
then processed for actin cytoskeleton
visualization.
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Pkc1 because the absence of Mpk1 did not rescue the G1 defect
because of the absence of Sit4 function (Fig. 6, B and C). This is
not strange since not all Pkc1 functions are mediated by Mpk1.
We conclude from these results that high PKC1-MAPK activity
induces a delay in the G1 to S phase progression, and that the
G1 delay that occurs in the absence of Sit4 would be mediated
by Pkc1.
DISCUSSION
One major finding of this study is that Sit4, a phosphatase
whose function has been related to cell cycle control and nutri-
tional state, is also involved in the functional regulation of the
Pkc1 pathway. Sit4 functions upstream of Pkc1 and compo-
nents of the PKC1-MAPK cascade, but downstream of the
Wsc1, Wsc2, and Mid2 plasma membrane receptors, and the
latter signal changes in cell wall integrity to Pkc1 via Rom2
and Rho1 (60). We also present evidence demonstrating that for
this function Sit4 also acts independently of Bem2 (a GTPase-
activating protein which regulates Rho1). The role of Sit4 in the
modulation of the pathway is reflected in: (i) maintenance of a
normal/basal level of Mpk1 activity throughout the cell cycle,
and (ii) down-regulation the PKC1-MAPK module once this has
been activated by external signals that affect cell membrane
integrity, such as heat shock. Therefore, two biological pro-
cesses that depend on Pkc1 activity via Mpk1 are affected by
Sit4: phosphorylation of Swi6, and basal expression of FKS1
(data not shown) involved in cell wall assembly (31, 33). Little
is known about the role that Pkc1-dependent Swi6 phosphoryl-
ation exercises in the cellular processes after heat shock, al-
though it is known that Swi6 is required for Pkc1-dependent
transcriptional induction of some cell wall genes after heat
shock (31). In addition, it has been reported that heat shock
and osmotic stress cause cells to transitorily accumulate at G1,
which correlates with a descent in the transcription of G1 cyclin
genes CLN1 and CLN2 (61, 62). However, no clear relationship
was observed between Swi6 phosphorylation after heat shock
and cyclin expression, either in sit4 or in wild type cells (data
not shown).
Another major novel finding addressed in this study is the
observation that Pkc1 overexpression and activation of the
pathway induce a prolonged G1 phase in exponentially growing
cultures. This function might help to explain the G1 to S defect
observed in sit4 mutants (14, 13), because such a defect is
rescued to wild type levels in a sit4-pkc1 double mutant.
Furthermore, the fact that the absence of Mpk1 does not com-
pensate for the sit4 growth defect suggests that the functional
interaction between Sit4 and Pkc1 in G1 cell cycle regulation is
specific to Pkc1 activity. Therefore, the G1 delay as a conse-
quence of the absence of Sit4 function is mediated by the
up-regulation of Pkc1 activity. Pkc1-mediated cell cycle regu-
lation is not a trivial matter, because overexpression of CLN2,
which shortens the G1 phase, does not compensate for the
greater Mpk1 activity observed in the mutant.2 Future studies
will contribute to clarify this function.
We have also addressed the question of whether the high
levels of Pkc1 and Mpk1 activity observed in sit4 cells were
merely a direct consequence of intrinsic cell wall problems.
This is apparently not the case, as osmotic stabilization of the
cell wall does not suppress up-regulation of Mpk1 activity. On
the contrary, the observation that this mutant displayed a cell
wall more resistant to zymolyase digestion could reflect two
processes: (i) an up-regulation of Rho1 in the absence of Sit4
that could lead to greater Fks1 activity, and (ii) an increase in
cell wall gene expression mediated by greater Mpk1 activity.
Our unpublished observations2 show that Sit4 is functionally
independent from the Ptp2 and Msg5 protein phosphatases,
and that these directly down-regulate Mpk1 activity (36, 37).
FIG. 5. Ribosomal gene expression upon alteration of the secretory pathway is also affected by the absence of Sit4. CML128 and
sit4 cells were grown exponentially in YPD at 25 °C, then shifted to 37 °C for 30 min (time 0). After that, cultures were either treated with 2.5
g/ml tunicamycin (A and B) or mock treated (C and D). Relative mRNA levels obtained at time 0 were assigned the value 1, the rest of the mRNA
relative levels obtained in the subsequent 3-h experiment were normalized with respect to this value. Error bars represent standard deviations
calculated from three independent experiments.
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BCK2 is a suppressor of the lethality caused by mutations in
the cell integrity pathway (27), and is also involved in the SIT4
pathway for CLN activation (15). This raised the possibility of
a functional relationship between BCK2 and SIT4 in control-
ling the activity in the PKC1-MAPK pathway. However, BCK2
does not act in the same pathway as SIT4 for this function,
because the kinetics of Mpk1 phosphorylation in bck2 cells
are very similar to those of wild type cells.2
The location of Sit4 upstream of Pkc1 in the cell integrity
pathway led us to hypothesize that it could contribute to the
modulation of other Pkc1-dependent biological processes that
are not directly regulated by Mpk1. Pkc1 plays a role in the
organization of the actin cytoskeleton but apparently does not
depend on Mpk1 (22). Heat shock stress induces a transient
depolarization of actin patch distribution in the cytoplasm.
This process, and the subsequent repolarization of actin, both
depend on Pkc1, although only the latter could also be medi-
ated by Mpk1 (22). The observation that in the absence of
functional Sit4 the actin cytoskeleton remains depolarized for
longer periods than in wild type cells is another indication of
the functional connection between Pkc1 and Sit4 and in turn
correlates to higher levels of Pkc1 activity in the absence of
Sit4.
Transcriptional repression of ribosomal genes upon impair-
ment of the secretory machinery is also dependent on Pkc1, but
independent of downstream elements of the pathway (58). This
process is also affected in sit4 cells, which again supports the
model in which the absence of Sit4 would affect a number of
biological processes acting through Pkc1 both in a Mpk1-de-
pendent and independent way. All these results are summa-
rized in Fig. 7.
Pph22, a type 2A protein phosphatase, has been reported as
having a positive role in cell wall integrity and cytoskeleton
organization (63). Glc7, a catalytic subunit of type 1 protein
serine/threonine phosphatases, functions positively to Pkc1 in
promoting cell integrity and polarization of the actin cytoskel-
eton (64). However, Sit4 is the only phosphatase, described to
date, whose role in PKC1-MAPK modulation would produce a
negative modulation upstream of Pkc1.
Sit4 is a phosphatase by sequence, and it is generally ac-
cepted that it influences the phosphorylation of a number of
substrates. However, there is no evidence of active dephospho-
rylation of such substrates by Sit4, because no specific bio-
chemical assay for this protein has yet been published.
Cell integrity pathway activity is necessary for survival.
However, if this pathway were not shut down when not re-
quired, a number of processes such as cell cycle, cytoskeleton
organization, and gene transcription, among others, would be
deregulated and this would affect cell growth and viability. In
this regard, Sit4 could contribute to maintaining correct phys-
FIG. 6. Pkc1 overexpression induces a G1 arrest. A, cultures of
CML128 and CML128 harboring a plasmid with Pkc1 under the tetO7
promoter were grown in minimum medium to log phase, then washed
several times to eliminate doxycycline to induce Pkc1 expression (see
“Materials and Methods”). Samples were taken at the indicated periods
for FACS analyses and Western blot. B, FACS profiles of the indicated
strains grown exponentially at 25 °C in YPD  1 M sorbitol. C, serial
dilutions of CML128, sit4, pkc1, sit4-pkc1, mpk1, and sit4-
mpk1 exponentially growing cultures in YPD plus 1 M sorbitol.
FIG. 7. Schematic model of the down-regulatory effect that
Sit4 exercises on Pkc1 biological functions. These are: actin cy-
toskeleton organization, ribosomal gene transcription, cell cycle regu-
lation at G1, and Mpk1 basal and induced activity that results in the
subsequent activation of a number of cellular responses to cell wall
stress, including transcriptional induction of genes involved in cell-wall
repair. Whether Swi6 phosphorylation signals the latter process re-
mains unclear. The function we attribute to Sit4 can probably be ex-
erted through regulation of various elements termed X, which in turn
directly interacts with Pkc1. Candidates for this are the known and/or
unknown upstream elements of the PKC1-MAPK pathway (cell wall
receptors, GTP-exchange factors, GTPase activating proteins, or
G-proteins).
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iological levels of PKC1-MAPK activity in cells. Further studies
are needed to characterize the direct substrate(s) on which Sit4
operates.
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